Hofland, K. F., Hansen, S., Sorensen, M., Engelholm, S., Schultz, H. P., Muhic, A., … Lassen, U. (2014). Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study. Acta Oncologica, 53(7), 939–944. https://doi.org/10.3109/0284186X.2013.879607